Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone add-on to reduce dexamethasone-related neurobehavioral side effects in children with ALL
NL-OMON23013Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of hydrocortisone in acute lymphoblastic leukemia (ALL) (2 arms), sponsored by Erasmus MC. Primary endpoint: Parent-reported Strengths and Difficulties Questionnaire score. Started May 2012; status: active, not recruiting.
02
Drugs
hydrocortisone
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NL-OMON23013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23013.